Novavax (NVAX) to Cease Negotiations with ROVI Pharma for Drug Collaboration

February 8, 2010 7:24 AM EST Send to a Friend
Novavax, Inc. (NASDAQ: NVAX) announced today that the company has decided to discontinue negotiations in its pursuit of the previously ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login